Polymorphism at position-308 of TNFalfa gene influences outcome of infliximab therapy in rheumatoid arthritis

被引：0
|
作者：
Mugnierl, B [1 ]
Balandraud, N [1 ]
Roudier, C [1 ]
Roudier, J [1 ]
Reviron, D [1 ]
机构：
[1] INSERM, EMI 9940, F-13258 Marseille, France
来源：
ANNALS OF THE RHEUMATIC DISEASES | 2003年 / 62卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：190 / 190
页数：1
相关论文
共 50 条
  • [31] Polymorphisms of the tumour necrosis factor α gene at position-308 and TNFd microsatellite in primary IgA nephropathy
    Tuglular, S
    Berthoux, P
    Berthoux, F
    [J]. NEPHROLOGY DIALYSIS TRANSPLANTATION, 2003, 18 (04) : 724 - 731
  • [32] Pharmacokinetics of infliximab therapy for rheumatoid arthritis (RA)
    St Clair, PW
    Wagner, C
    Wang, B
    Schaible, T
    Fasanmade, A
    Kavanaugh, AF
    Keystone, EC
    [J]. ARTHRITIS AND RHEUMATISM, 2001, 44 (09): : S214 - S214
  • [33] Toll like receptor 4 polymorphism influences susceptibility to but not severity and outcome of rheumatoid arthritis
    Radstake, TRDJ
    Franke, B
    Hanssen, S
    Welsing, R
    Joosten, LAB
    Van Riel, RCM
    Barrera, R
    Van den Berg, WB
    [J]. ANNALS OF THE RHEUMATIC DISEASES, 2004, 63 : 164 - 164
  • [34] Association between IL10 gene polymorphism and clinical response to infliximab in rheumatoid arthritis
    Lampa, J
    van Vollenhoven, RF
    Klareskog, L
    Padyukov, L
    [J]. ARTHRITIS AND RHEUMATISM, 2002, 46 (09): : S136 - S137
  • [35] Treatment with infliximab influences circulating nucleosomes in rheumatoid arthritis patients
    Manfredi, AA
    Raffaele, HS
    [J]. ARTHRITIS AND RHEUMATISM, 2002, 46 (09): : S133 - S133
  • [36] A variant of position-308 of the tumour necrosis factor alpha gene promoter and the risk of coronary heart disease
    Elahi, Maqsood M.
    Gilmour, Ashley
    Matata, Bashir M.
    Mastana, Sarabjit S.
    [J]. HEART LUNG AND CIRCULATION, 2008, 17 (01): : 14 - 18
  • [37] Association of the A Allele of the TNF-Alpha-308 G/A Gene Polymorphism with Radiographic Progression in Rheumatoid Arthritis
    Stojanovic, Sonja
    Stamenkovic, Bojana
    Nedovic, Jovan
    Jevtovic-Stoimenov, Tatjana
    Pavlovic, Dusica
    [J]. ACTA FACULTATIS MEDICAE NAISSENSIS, 2018, 35 (01) : 30 - 36
  • [38] Influence of-308 A/G polymorphism in the tumor necrosis factor α gene on etanercept treatment in rheumatoid arthritis
    Guis, Sandrine
    Balandraud, Nathalie
    Bouvenot, Julien
    Auger, Isabelle
    Toussirot, Eric
    Wendling, Daniel
    Mattei, Jean-Pierre
    Nogueira, Leonor
    Mugnier, Benedicte
    Legeron, Pierre
    Landt, Olfert
    Serre, Guy
    Roudier, Jean
    Roudier, Chantal
    [J]. ARTHRITIS & RHEUMATISM-ARTHRITIS CARE & RESEARCH, 2007, 57 (08): : 1426 - 1430
  • [39] Tumour necrosis factor a −308 promoter polymorphism in patients with rheumatoid arthritis
    Zahra Rezaieyazdi
    Jalil Tavakol Afshari
    Mahnaz Sandooghi
    Farnaz Mohajer
    [J]. Rheumatology International, 2007, 28 : 189 - 191
  • [40] The influence of a polymorphism at position-857 of the tumour necrosis factor α gene on clinical response to etanercept therapy in rheumatoid arthritis
    Kang, CP
    Lee, KW
    Yoo, DH
    Kang, C
    Bae, SC
    [J]. RHEUMATOLOGY, 2005, 44 (04) : 547 - 552
12345